# Nutrinia

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nutrinia

- Industry: Biotechnology
- Headquarters: Ramat Gan, Israel
- Website: www.nutrinia.com
- Total disclosed funding: $43M
- Latest round: Series D (Aug 18, 2016)
- Investors on record: 7

## About

Founded in 2003 and based in Israel, Nutrinia develops oral insulin therapies to treat rare gastrointestinal disorders.

## Funding rounds

- Series D, Aug 18, 2016, $30M — OrbiMed Advisors, H.I.G. BioHealth Partners, Pontifax Venture Capital, TPG Biotech, 6 Dimensions Capital
- Series C, Dec 18, 2014, $12M — OrbiMed Advisors, Pontifax Venture Capital, Jacobs Investments
- Series A, Jun 22, 2005, $1M — New Generation Technologies

## Investors

- New Generation Technologies (https://capitalatlas.ai/funds/new-generation-technologies) — Series A
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series C, Series D
- Pontifax Venture Capital (https://capitalatlas.ai/funds/pontifax-venture-capital) — Series C, Series D
- Jacobs Investments (https://capitalatlas.ai/funds/jacobs-investments) — Series C
- H.I.G. BioHealth Partners (https://capitalatlas.ai/funds/h-i-g-biohealth-partners) — Series D
- TPG Biotech (https://capitalatlas.ai/funds/tpg-biotech) — Series D
- 6 Dimensions Capital (https://capitalatlas.ai/funds/6-dimensions-capital) — Series D